Back to Library

Johnson & Johnson

Brook Spent Years Searching for the Right Diagnosis

Written by
Johnson & Johnson logoJohnson & Johnson
• Published March 13, 2026 • Updated March 13, 2026 Sponsored Content
Brook Spent Years Searching for the Right Diagnosis

Sponsored by Johnson & Johnson.

For years, Brook, a mom of four who loves spending time outdoors, struggled with depression symptoms that she couldn’t quite explain. It wasn’t until much later that she would learn she had bipolar I depression. Johnson & Johnson creative content

Bipolar depression is part of a larger mental health condition called bipolar disorder, which causes extreme changes in mood and behavior. These changes in mood, known as mood episodes, can cause a person to experience lows (bipolar depression) and highs (mania).

A mom searching for answers

Brook experienced depression symptoms for most of her life, but after having her daughter, those feelings became overwhelming, making everyday tasks nearly impossible.

“The feelings of worry and fear consumed me. I would go to work and come home and go straight to my room. It was debilitating.”

—Brook, living with bipolar I depression

She saw different doctors and tried several medications, but didn’t find the improvement she needed.

Johnson & Johnson creative content

Brook’s Misconception About Bipolar Depression

For years, Brook's symptoms went undiagnosed, until she finally saw a psychiatrist who diagnosed her with bipolar I depression. Initially, Brook was doubtful, because of her family history. Johnson & Johnson creative content

“I didn’t believe it. I have a family member who has bipolar I, and my symptoms were so different than theirs.”

—Brook, living with bipolar I depression

The lows and highs of bipolar disorder

The lows of bipolar disorder, also known as depressive episodes, can make people feel sad or hopeless. They may lose interest or pleasure in most activities, even those they once enjoyed. These depressive episodes may be present throughout their lives, and some episodes may even last several months.

The highs of bipolar disorder, also known as manic or hypomanic episodes, can cause people to feel euphoric, impulsive, unusually irritable, or have an abnormal amount of increased energy.

After finally getting the right diagnosis, Brook and her doctor explored treatment options.

Bipolar depression can be difficult for healthcare professionals to diagnose and treat. Studies show that people with bipolar disorder are often misdiagnosed as having another kind of depression, called major depressive disorder, because the symptoms are so similar.Johnson & Johnson creative content

“I think the biggest misconception is that everyone with bipolar depression has the same symptoms.”

—Brook, living with bipolar I depression

Exploring Treatment with CAPLYTA® (lumateperone)

Brook's psychiatrist introduced CAPLYTA, a once-daily pill proven to deliver significant symptom relief from bipolar I and II depression in adults. Brook talked with her doctor about the benefits and risks of treatment. She felt hopeful that CAPLYTA could be a good fit.Johnson & Johnson creative content

“What I liked about CAPLYTA is that it’s proven to deliver significant relief from depressive symptoms for bipolar I or II disorder. The dosing is convenient. I take one pill, once a day, with or without food.”

—Brook, living with bipolar I depression

Patient experiences may vary.

CAPLYTA is proven to provide significant relief from depressive symptoms of bipolar disorder in adults at 6 weeks.

CAPLYTA has Boxed WARNINGS for increased risk of death in elderly people with dementia-related psychosis and increased risk of suicidal thoughts and behaviors in children and young adults. CAPLYTA is not approved for people under 18. See additional Important Safety Information below.

Johnson & Johnson creative content

Seeing a Difference in Her Depression Symptoms

Brook liked hearing that in CAPLYTA clinical trials, weight gain was not common, and she was optimistic this might be the right treatment for her.

CAPLYTA may cause problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels and weight before you start and during your treatment with CAPLYTA.

Please see additional Important Safety Information below.

After taking CAPLYTA, Brook began experiencing some relief from her depressive symptoms.

Johnson & Johnson creative content

"I’m really proud of myself for getting through my darkest days. There are still days where I feel down. On those days, I turn to my family for support, and we work through it together."

—Brook, living with bipolar I depression

Patient experiences may vary.

Johnson & Johnson creative content

Through the treatment process, Brook’s husband discovered a CAPLYTA access program that saved on her prescription at the pharmacy. For Eligible Commercially Insured patients only. Click here for full Eligibility Criteria and Terms & Conditions.

Through her journey, Brook has advocated that other people who suffer from bipolar I depression speak out and find the support they need. She knows living with bipolar I depression isn’t easy, but listening to stories of other people with the same condition helps remind you that you are not alone.

Watch a video of Brook's experience with bipolar I depression.

Learn more about how CAPLYTA can provide symptom relief for bipolar I depression.

The patient in this promotional article is sharing her individual experiences and has been compensated for her time. This promotional resource is brought to you by Johnson & Johnson.



IMPORTANT SAFETY INFORMATION

What is the most important information I should know about CAPLYTA®?

  • Medicines like CAPLYTA® can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA® is not approved for treating people with dementia-related psychosis.
  • CAPLYTA® and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions.
    • Patients and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when CAPLYTA® or an antidepressant medicine is started or when the dose is changed.
    • Report any changes in these symptoms to your healthcare provider immediately.
      • thoughts about suicide or dying
      • acting aggressive, being angry or violent
      • panic attacks
      • new or worse depression
      • new or worse anxiety
      • new or worsening irritability 
      • feeling very agitated or restless
      • suicide attempts
      • acting on dangerous impulses
      • trouble sleeping
      • an extreme increase in activity and talking (mania)
      • other unusual changes in behavior or mood

Do not take CAPLYTA® if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (e.g., rash, itching, hives, swelling of the tongue, lip, face, or throat).

What are the possible side effects of CAPLYTA®?

CAPLYTA® may cause serious side effects, including:

  • Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
  • Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of a rare but potentially fatal condition. Contact your healthcare provider or go to the emergency room if you experience signs and symptoms of NMS.
  • Uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA®. It may also occur after you stop taking CAPLYTA®.
  • Problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA®.
    • Extremely high blood sugar levels can lead to coma or death. Call your healthcare provider if you have symptoms such as feeling very thirsty, hungry, sick to your stomach, needing to urinate more than usual, weak/tired, confused, or fruity-smelling breath.
  • Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment.
  • Decreased blood pressure (orthostatic hypotension). You may feel lightheaded, dizzy, or faint when rising too quickly.
  • Falls. CAPLYTA® may make you sleepy or dizzy, lower your blood pressure, and slow thinking and motor skills which may lead to falls that can cause fractures or other injuries.
  • Seizures (convulsions).
  • Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Until you know how Caplyta® affects you, do not drive, operate heavy machinery, or do other dangerous activities.
  • Problems controlling your body temperature so that you feel too warm. Avoid getting overheated or dehydrated while taking Caplyta®.
  • Difficulty swallowing that can cause food or liquid to get into the lungs.

The most common side effects of CAPLYTA® include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea. 
These are not all the possible side effects of CAPLYTA®.

Before taking CAPLYTA®, tell your healthcare provider about all of your medical conditions, including if you: have or have had heart problems or a stroke, high or low blood pressure, diabetes, high blood sugar, cholesterol problems, low white blood cell count, seizures, or kidney or liver problems.

CAPLYTA® may cause fertility problems. Notify your healthcare provider if you become pregnant or intend to become pregnant. There is a pregnancy registry for females exposed during pregnancy. CAPLYTA® may cause abnormal involuntary movements and/or withdrawal symptoms in newborns exposed during the third trimester. Talk to your healthcare provider if you breastfeed or plan to breastfeed.

Tell your healthcare provider about all the medicines you're taking. CAPLYTA® may affect how other medicines work and vice versa. Do not start or stop medicines without talking to your healthcare provider. Report negative side effects to Intra-Cellular Therapies, Inc. at 1-888-611-4824 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

CAPLYTA® is available in 42 mg, 21 mg, and 10.5 mg capsules.

What is CAPLYTA® (lumateperone)?

CAPLYTA® (lumateperone) is a prescription medicine used in adults to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate. It is not known if CAPLYTA® is safe and effective in children.

US-CAP-2500883

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for CAPLYTA®.

© Johnson & Johnson and its affiliates 2026

CAPLYTA is a trademark of Johnson & Johnson and its affiliates.

Third party trademarks listed are the property of their respective owners.

03/26 US-CAP-2600074